Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Laryngeal Diseases 2Hypopharyngeal Neoplasms 2Head and Neck Neoplasms 2Carcinoma, Squamous Cell 2Squamous Cell Carcinoma of Head and Neck 1Papilloma 1Oropharyngeal Neoplasms 1Nasopharyngeal Carcinoma 1Margins of Excision 1Laryngeal Neoplasms 1Esophageal Neoplasms 1

Interventions

Cisplatin 127Gemcitabine 71Radiotherapy, Intensity-Modulated 61toripalimab 39Capecitabine 37Docetaxel 36Fluorouracil 35Radiotherapy 24camrelizumab 23Drug Therapy 22nimotuzumab 18spartalizumab 13pembrolizumab 13nedaplatin 12Chemoradiotherapy 12sintilimab 11apatinib 11Induction Chemotherapy 11Immune Checkpoint Inhibitors 11tislelizumab 10Nivolumab 10Magnetic Resonance Spectroscopy 10Specimen Handling 9Radiation 9Cetuximab 9Carboplatin 9endostar protein 8Paclitaxel 8Bevacizumab 8anlotinib 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Nasopharyngeal Carcinoma × Narrow Band Imaging × Head & Neck × Clear all
NCT04593186 2023-09-07

Magnifying NBI for Occult NPC

Chinese University of Hong Kong

Phase NA Unknown
246 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡